ATE493118T1 - Biologisch wirksame zusammensetzung mit ethylcellulose - Google Patents

Biologisch wirksame zusammensetzung mit ethylcellulose

Info

Publication number
ATE493118T1
ATE493118T1 AT06844392T AT06844392T ATE493118T1 AT E493118 T1 ATE493118 T1 AT E493118T1 AT 06844392 T AT06844392 T AT 06844392T AT 06844392 T AT06844392 T AT 06844392T AT E493118 T1 ATE493118 T1 AT E493118T1
Authority
AT
Austria
Prior art keywords
ethylcellulose
biologically effective
effective composition
composition
biologically active
Prior art date
Application number
AT06844392T
Other languages
English (en)
Inventor
Mark J Hall
Karen A Coppens
Pamela S Larsen
Shawn A Mitchell
Michael D Read
Uma Shrestha
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Application granted granted Critical
Publication of ATE493118T1 publication Critical patent/ATE493118T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT06844392T 2006-01-19 2006-11-17 Biologisch wirksame zusammensetzung mit ethylcellulose ATE493118T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76025306P 2006-01-19 2006-01-19
US78893806P 2006-04-04 2006-04-04
PCT/US2006/044557 WO2007084212A2 (en) 2006-01-19 2006-11-17 Biologically active composition comprising ethylcellulose

Publications (1)

Publication Number Publication Date
ATE493118T1 true ATE493118T1 (de) 2011-01-15

Family

ID=37898565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06844392T ATE493118T1 (de) 2006-01-19 2006-11-17 Biologisch wirksame zusammensetzung mit ethylcellulose

Country Status (9)

Country Link
US (1) US9198865B2 (de)
EP (1) EP1978940B1 (de)
JP (1) JP5249050B2 (de)
CN (1) CN101360483B (de)
AT (1) ATE493118T1 (de)
CA (1) CA2636339C (de)
DE (1) DE602006019320D1 (de)
IL (1) IL192611A (de)
WO (1) WO2007084212A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2010005341A0 (en) * 2008-01-11 2010-08-31 Cipla Ltd Solid pharmaceutical dosage form
CN102892815B (zh) * 2010-03-26 2016-05-18 陶氏环球技术有限责任公司 熔体挤出的膜
JP5827310B2 (ja) * 2010-03-26 2015-12-02 ダウ グローバル テクノロジーズ エルエルシー 溶融押出フィルム
BR112014004753A2 (pt) 2011-08-30 2017-03-28 Univ Gent formulação de liberação de multicamadas
WO2017019393A1 (en) * 2015-07-27 2017-02-02 Dow Global Technologies Llc Method to additive manufacture biocompatible material and articles made by the method
EP3459527B1 (de) 2017-09-20 2022-11-23 Tillotts Pharma Ag Verfahren zur herstellung einer festen dosierungsform mit antikörpern durch nassgranulation, -extrusion und -sphäronisierung
WO2019069194A1 (en) * 2017-10-02 2019-04-11 Novartis Ag PROCESS FOR PRODUCING A PHARMACEUTICAL MEDIUM
WO2020131800A1 (en) 2018-12-18 2020-06-25 DDP Specialty Electronic Materials US, Inc. A sustained release composition comprising an ethylcellulose
US20220062305A1 (en) 2018-12-18 2022-03-03 DDP Specialty Electronic Materials US, Inc. Sustained release composition comprising an ethylcellulose

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2257104A (en) 1939-11-09 1941-09-30 Du Pont Extrusion method for organic materials
US3941865A (en) 1973-12-10 1976-03-02 Union Carbide Corporation Extrusion of ethylene oxide resins
US4645812A (en) 1983-02-28 1987-02-24 Henkel Corporation Method of suspension polymerization of vinyl chloride
US4678516A (en) 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
TW207987B (de) 1991-03-20 1993-06-21 Hoechst Ag
PT1014941E (pt) * 1996-06-26 2009-07-08 Univ Texas Formulação farmacêutica extrudível por termofusão
US5966582A (en) 1996-10-28 1999-10-12 Corning Incorporated Method for rapid stiffening of extrudates
GT199900148A (es) * 1998-09-10 2001-02-28 Desnaturalizantes para las sales aminas simpaticomimeticas.
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
AU2001239838A1 (en) * 2000-02-24 2001-09-03 Advancis Pharmaceutical Corporation Therapeutic product, use and formulation thereof
WO2002035991A2 (en) 2000-10-30 2002-05-10 The Board Of Regents, The University Of Texas System Spherical particles produced by a hot-melt extrusion/spheronization process
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
DE602004014747D1 (de) * 2003-03-26 2008-08-14 Egalet As Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen

Also Published As

Publication number Publication date
IL192611A (en) 2012-12-31
EP1978940B1 (de) 2010-12-29
US20090130058A1 (en) 2009-05-21
DE602006019320D1 (de) 2011-02-10
CA2636339C (en) 2014-07-08
JP2009523793A (ja) 2009-06-25
IL192611A0 (en) 2009-02-11
CA2636339A1 (en) 2007-07-26
CN101360483A (zh) 2009-02-04
US9198865B2 (en) 2015-12-01
CN101360483B (zh) 2012-10-31
WO2007084212A3 (en) 2007-12-06
WO2007084212A2 (en) 2007-07-26
EP1978940A2 (de) 2008-10-15
JP5249050B2 (ja) 2013-07-31

Similar Documents

Publication Publication Date Title
IL192611A0 (en) Biologically active composition comprising ethylcellulose
CO6420388A2 (es) Formulacion que comprende particulas de avermectina cubiertas con un agente fotoprotector
DE602007012692D1 (de) Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan
DK1603565T3 (da) Medikament omfattende en höjaktiv længevarende beta2-agonisk i kombination med andre aktive ingredienser
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
IS6344A (is) Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja
HRP20151202T1 (hr) Oralna formulacija metadoksina
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
SI1933809T1 (sl) Sestavki za mazalno dajanje
AR059097A1 (es) Tratamiento a largo plazo de la infeccion por vih
PL2120864T3 (pl) Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
IT1362675B (it) N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
DE602006020070D1 (de) Verringerung von schwindel, einer nebenwirkung im zusammenhang mit einer pirfenidon-therapie
DE602007011316D1 (de) Pharmazeutische zusammensetzung mit antipsychotischer, antidepressiver oder antiepileptischer wirkung mit verringerter nebenwirkung
BRPI0405662A (pt) Emplastros contendo turobuterol
EA200870155A1 (ru) Система доставки лекарственного средства
EA200970798A1 (ru) Композиция для лечения диабета 2 типа
DE60312642D1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
ATE449101T1 (de) Salze von clopidogrel mit polyanionen und ihre verwendung zur herstellung pharmazeutischer formulierungen
RU2006113043A (ru) Регулятор роста и развития сельскохозяйственных культур
CL2007003277A1 (es) Compuestos derivados de sulopenem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties